AI-PROGNOSIS - Digital Biomarkers Development Study (dBM-DEV)

计划入组 90 人 · 首次发布于 2024 年 6 月 6 日

A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine

计划入组 41 人 · 首次发布于 2025 年 7 月 23 日

Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine

计划入组 120 人 · 首次发布于 2017 年 2 月 23 日

DEV-2011

DEV-2015

Kv4.3 voltage-dependent potassium channel antagonists (Devgen)

KNOWLTON DEV CORP INC

Pelican Therapeutics, Inc.

United States

The State University of New York

United States

Ever Supreme's Allogeneic Solid Tumor CAR-T CAR001 Advances to Phase IIa, Targets 2028 Taiwan Provisional Approval

Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury

PharmD Summer Research Fellows Study Real-World Safety of a Novel Schizophrenia Treatment